Rhode Island legislation · 2026 Regular Session
Rhode Island H7617: AN ACT RELATING TO HEALTH AND SAFETY -- HEALTH AND SAFETY OF PUPILS (Provides that where the administration, use, or maintenance
Status: In committee, June 9, 2026
AN ACT RELATING TO HEALTH AND SAFETY -- HEALTH AND SAFETY OF PUPILS (Provides that where the administration, use, or maintenance of epinephrine within schools and on buses is authorized, this use includes epinephrine delivery devices approved by the United States Food & Drug Administration and epinephrine nasal sprays.)
What the bill says
From the introduced text, February 11, 2026:
2026 -- H 7617 ======== LC004770 ======== STATEOFRHODEISLAND IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 2026 ____________ ANACT RELATING TO HEALTH AND SAFETY -- HEALTH AND SAFETY OF PUPILS Introduced By: Representatives Donovan, Cotter, Boylan, Speakman, Fogarty, Biah, and Tanzi Date Introduced: February 11, 2026 Referred To: House Education It is enacted by the General Assembly as follows: SECTION 1. Section 16-21-22 of the General Laws in Chapter 16-21 entitled "Health and Safety of Pupils" is hereby amended to read as follows: 16-21-22. Allergic emergencies -- Anaphylaxis -- Use of epinephrine -- Immunity for those administering. (a) The department of elementary and secondary education and the department of health shall incorporate into their policies, rules, and regulations pertaining to school health programs a procedure for addressing incidents of anaphylaxis (exaggerated allergic reaction) in order to provide for the health and safety of children who have been medically identified as being prone to anaphylaxis or who show evidence of anaphylaxis. The policies, rules, and regulations shall include a procedure whereby a parent or legal guardian of any child may expressly authorize the school department and school bus drivers and monitors to administer the epinephrine on his or her child in case of an emergency and ensures that the epinephrine is kept in a conspicuous place, readily available, and that their proper use …
Sponsors
- Susan Donovan (D, HD-069) · primary sponsor
- Megan Cotter (D, HD-039)
- Jennifer Boylan (D, HD-066)
- June Speakman (D, HD-068)
- Kathleen Fogarty (D, HD-035)
- Nathan Biah (D)
- Teresa Tanzi (D, HD-034)
Latest actions
- : Referred to Senate Health and Human Services
- : House passed Sub A
- : Placed on House Calendar
- : Committee recommends passage of Sub A
- : Proposed Substitute
- : Scheduled for consideration
- : Committee recommended measure be held for further study
- : Scheduled for hearing and/or consideration
- : Introduced, referred to House Education
Votes
- House Seq #212: PASSAGE (May 28, 2026): 63 yea, 0 nay, passed
- House Committee on Education: Passage of Sub A (May 19, 2026): 10 yea, 0 nay, passed
- Senate Seq #714: (June 14, 2024): 32 yea, 4 nay, passed
Subjects: HEALTH AND SAFETY
Common questions
- What is H7617?
- H7617 is a bill in the Rhode Island Legislature (2026 Regular Session): AN ACT RELATING TO HEALTH AND SAFETY -- HEALTH AND SAFETY OF PUPILS (Provides that where the administration, use, or maintenance.
- What does H7617 do?
- AN ACT RELATING TO HEALTH AND SAFETY -- HEALTH AND SAFETY OF PUPILS (Provides that where the administration, use, or maintenance of epinephrine within schools and on buses is authorized, this use includes epinephrine delivery devices approved by the United States Food & Drug Administration and epinephrine nasal sprays.)
- What is the status of H7617?
- In committee as of June 9, 2026. Latest action: Referred to Senate Health and Human Services (June 9, 2026).
- Who sponsored H7617?
- Susan Donovan (D, HD-069), with 6 co-sponsors.
- Where is the official record for H7617?
- On the Rhode Island Legislature website: http://webserver.rilegislature.gov/BillText/BillText26/HouseText26/H7617A.pdf
Source: official Rhode Island record. Tracked by Delilah, AI for legislation across all 50 states and Congress.